Stay updated on Amivantamab Clinical Trial in Advanced NSCLC

Sign up to get notified when there's something new on the Amivantamab Clinical Trial in Advanced NSCLC page.
Latest website image capture
Clouds background image

Latest updates to the Amivantamab Clinical Trial in Advanced NSCLC page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    Change Detected
    Summary
    The record describes the CHRYSALIS Phase 1 study of amivantamab alone and in combination treatments for advanced non-small cell lung cancer. It provides eligibility requirements, study locations, treatment arms, outcome measures, and indicates the study is active but not recruiting.
    Difference
    76%
    Check dated 2026-11-07T15:18:19.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    The footer now identifies the site as revision v3.8.0 instead of v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-31T15:45:49.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    An NIH announcement about website changes and the use of “Super Intelligence” appears above the 403 error page.
    Difference
    1%
    Check dated 2026-10-24T16:06:49.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.1 to v3.7.2 on the page displaying a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-17T15:53:04.000Z thumbnail image
  6. Check
    35 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.0 to v3.7.1 while the page remained a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T16:02:03.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    A 403 Forbidden error page is now shown for the study record, replacing the expected content. The additions include the 403 message and HTML skeleton, and many trial metadata terms appear to have been removed, indicating restricted access to the record.
    Difference
    17%
    Check dated 2026-09-19T20:01:54.000Z thumbnail image

Stay in the know with updates to Amivantamab Clinical Trial in Advanced NSCLC

Enter your email address, and we'll notify you when there's something new on the Amivantamab Clinical Trial in Advanced NSCLC page.